Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8674-8681

  Jia, Yifeng ^a,b   Zeng, Zhao Zhu ^a   Markwart, Sonja M ^a   Rockwood, Korrene F ^a   Woods Ignatoski, Kathleen M ^a   Ethier, Stephen P ^a,c   Livant, Donna L ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d 1331 East Ann Street Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN RECEPTOR; INTEGRIN; INTERSTITIAL COLLAGENASE; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS INHIBITION; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASEMENT MEMBRANE; BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL CELLS; FIBRONECTINS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHA5BETA1; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASE 1; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS;

EID: 9244237086     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0069     Document Type: Article

References (50)

1. Geiger B, Bershadsky A, Pankov R, Yamada KM. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001;2:793-805.
2. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001;189:1-13.
3. Livant DL, Brabec RK, Kurachi K, et al. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Investig 2000;105:1537-45.
4. While ES, Livant DL, Markwart S, Arenberg DA. Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependem angiogenic activity. J Immunol 2001;167:5362-6.
5. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R. Integrins in invasive growth. J Clin Investig 2002;109:999-1006.
6. Livant DL, Brabec RK, Pienta KJ, et al. Anti-invasive, antitumorigenic, and anti-metastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res 2000;60:309-20.
7. van Golen KL, Bao L, Brewer GJ, et al. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia 2002;4:373-9.
8. Yamada KM. Fibronectin peptides in cell migration and wound repair. J Clin Investig 2000;105:1507-9.
9. Gibson AW, Burke RD. Migratory and invasive behavior of pigment cells in normal and animalized sea urchin embryos. Exp Cell Res 1987;173:546-57.
10. Livant DL, Linn S, Markwart S, Shuster J. Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res 1995;55:5085-93.
11. Noel AC, Calle A, Emonard HP, et al. Invasion of reconstituted basement membrane matrix is not correlated to the malignant metastatic cell phenotype. Cancer Res 1991;51:405-14.
12. Amemiya S. Development of the basal lamina and its role in migration and pattern formation of primary mesenchyme cells in sea urchin embryos. Dev Growth Differ 1989;31:131-45.
13. McCarthy RA, Beck K, Burger MM. Laminin is structurally conserved in the sea-urchin basal lamina. EMBO J 1987;6:1587-93.
14. Solursh M, Katow H. Initial characterization of sulfated macromolecules in the blastocoels of mesenchyme blastulae of Strongylocentrotus-purpuratus and Lytechinus-pictus. Dev Biol 1982;94:326-36.
15. Huhtala P, Humphries MJ, McCarthy JB, et al. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995;129:867-79.
16. Grinnell F, Zhu M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Investig Dermatol 1994;103:155-61.
17. Greiling D, Clark RA. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 1997;110:861-70.
18. Rokhlin OW, Cohen MB. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate 1995;26:205-12.
19. Ignatoski KM, Maehama T, Markwart SM, et al. ERBB-2 overexpression confers PI 3′ kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer 2000;82:666-74.
20. Mosher DF. Physiology of fibronectin. Annu Rev Med 1984;35:561-75.
21. Ruoslahti E, Hayman EG, Pierschbacher M, Engvall E. Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 1982;82:803-31.
22. Ethier SP, Mahacek ML, Gullick WJ, Frank TS, Weber BL. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 1993;53:627-35.
23. Ignatoski KM, Ethier SP. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat 1999;54:173-82.
24. Atherton E, Sheppard RC. Solid phase peptide synthesis: a practical approach. Oxford, United Kingdom: IRL Press; 1989.
25. Wayner EA, Carter WG, Piotrowicz RS, Kunicki TJ. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 1988;107:1881-91.
26. Carter WG, Wayner EA, Bouchard TS, Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990;110:1387-404.
27. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-I) in plasma fibronectin. J Cell Biol 1989;109:1321-30.
28. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 1993;121:1141-52.
29. Birkedal-Hansen B, Moore WG, Taylor RE, Bhown AS, Birkedal-Hansen H. Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme. Biochemistry 1988;27:6751-8.
30. Fridman R, Fuerst TR, Bird RE, et al. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 1992;267:15398-405.
31. Schnaper HW, Grant DS, Stetler-Stevenson WG, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-46.
32. Aota S, Nomizu M, Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994;269:24756-61.
33. Altroff H, van der Walle CF, Asselin J, et al. The eight Fill domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth Fill domain. J Biol Chem 2001;276:38885-92.
34. Komoriya A, Green LJ, Mervic M, et al. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type 111 connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 1991;266:15075-9.
35. Dumin JA, Dickeson SK, Stricker TP, et al. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type 1 collagen. J Biol Chem 2001;276:29368-74.
36. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
37. Varghese S, Delany AM, Liang L, et al. Transcriptional and posttranscriptional regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures. Endocrinology 1996;137:431-7.
38. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189:300-8.
39. Garbett EA, Reed MW, Stephenson TJ, Brown NJ. Proteolysis in human breast cancer. Mol Pathol 2000;53:99-106.
40. Nakopoulou L, Giannopoulou I, Gakiopoulou H, et al. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999;30:436-42.
41. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.
42. Remacle AG, Noel A, Duggan C, et al. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer 1998;77:926-31.
43. Brummer O, Athar S, Riethdorf L, Loning T, Herbst H. Matrix- metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch 1999;435:566-73.
44. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 1995;71:1039-45.
45. Sires UI, Griffin GL, Broekelmann TJ, et al. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 1993;268:2069-74.
46. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
47. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-61.
48. Shiozawa J, Ito M, Nakayama T, et al. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 2000;13:925-33.
49. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5.
50. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61:7825-9.